Pangen Biotech Inc
222110
Company Profile
Business description
Pangen Biotech Inc is a biotechnology company. It is engaged in development of biosimilar products and technology transfer services for biologics development. It develops biosimilar products, such as EPO, recombinant factor VIII, G-CSF, etc.
Contact
4Floor Innoplex 2-dong
306 Sinwon-ro, Yeongtong-gu
Gyeonggi-do
Suwon-si16675
KORT: +82 317339165
Sector
Healthcare
Stock type
Defensive
Industry
Biotechnology
Fiscal Year End
31 December 2025
Employees
76
Stocks News & Analysis
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 7,920.20 | 358.50 | 4.74% |
| CAC 40 | 6,863.02 | 237.40 | -3.34% |
| DAX 40 | 19,670.88 | 609.38 | -3.00% |
| Dow JONES (US) | 40,205.73 | 340.20 | -0.84% |
| FTSE 100 | 7,679.48 | 231.05 | -2.92% |
| HKSE | 20,818.92 | 554.43 | 2.74% |
| NASDAQ | 16,836.27 | 285.66 | 1.73% |
| Nikkei 225 | 34,353.17 | 2,639.14 | 8.32% |
| NZX 50 Index | 12,203.19 | 396.64 | 3.36% |
| S&P 500 | 5,381.00 | 398.23 | 7.99% |
| S&P/ASX 200 | 7,719.30 | 344.30 | 4.67% |
| SSE Composite Index | 3,221.04 | 34.23 | 1.07% |